Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity

Journal of Bone and Mineral Research

Volumn 25, Issue 4, 2010, Pages 796-808

  Larsen, Kenneth H ^a   Frederiksen, Casper M ^a   Burns, Jorge S ^a   Abdallah, Basem M ^a   Kassem, Moustapha ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Biomarkers; Bone formation; Bone marrow stromal cells (BMSCS); DNA microarrays; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE SIALOPROTEIN; COLLAGEN TYPE 1; DECORIN; DNA; LYSYL OXIDASE LIKE 4; NATRIURETIC PEPTIDE RECEPTOR C; OSTEOPONTIN; PROTEIN LYSINE 6 OXIDASE; TETRANECTIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HETEROTOPIC OSSIFICATION; IMMUNE RESPONSE; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PREDICTION; PREDICTIVE VALIDITY; PROMOTER REGION; QUALITY CONTROL; STROMA CELL;

AMINO ACID OXIDOREDUCTASES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENES, MHC CLASS II; HUMANS; LECTINS, C-TYPE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; PROTEOGLYCANS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SP3 TRANSCRIPTION FACTOR; STROMAL CELLS;

EID: 77953460769     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091018     Document Type: Article

References (59)

1. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313-319. (Pubitemid 351467394)
2. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393-403.
3. Kassem M, Mosekilde L, Eriksen EF. 1,25-Dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. J Bone Miner Res. 1993;8:1453-1458. (Pubitemid 23342682)
4. Kuznetsov SA, Krebsbach PH, Satomura K, et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res. 1997;12:1335-1347. (Pubitemid 27375376)
5. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147. (Pubitemid 29282067)
6. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008;15:109-116.
7. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 2001;344:385-386. (Pubitemid 32107654)
8. Robey PG, Bianco P. The use of adult stem cells in rebuilding the human face. J Am Dent Assoc. 2006;137:961-972. (Pubitemid 44153896)
9. Parfitt AM. Bone forming cells in clinical conditions. In: Hall BK, ed. In Bone, The Osteoblast and Osteocyte. London: Telford Press; 1991:351-426.
10. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841-846. (Pubitemid 37351468)
11. Aubin JE, Triffitt JT. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian JP, Raisz LG, Rodan GA, eds. The Principles of Bone Biology, 2nd edition. San Diego, CA: Academic Press; 2002:59-81.
12. Rodan GA, Noda M. Gene expression in osteoblastic cells. Crit Rev Eukaryot Gene Expr. 1991;1:85-98.
13. Abdallah BM, Ditzel N, Kassem M. Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis. Methods Mol Biol. 2008;455:89-100.
14. Dennis JE, Konstantakos EK, Arm D, Caplan AI. In vivo osteogenesis assay: a rapid method for quantitative analysis. Biomaterials. 1998;19:1323-1328.
15. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng. 2001;72:96-107.
16. Stenderup K, Rosada C, Justesen J, Al-Soubky T, Gnaes-Hansen F, Kassem M. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology. 2004;5:107-118. (Pubitemid 39137527)
17. Djouad F, Bony C, Haupl T, et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther. 2005;7:R1304-R1315.
18. Qi H, Aguiar DJ, Williams SM, La PA, Pan W, Verfaillie CM. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA. 2003;100:3305-3310. (Pubitemid 36356578)
19. Scheideler M, Elabd C, Zaragosi LE, et al. Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis. BMC Genomics. 2008;9:340.
20. Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol. 2007;271:1-117. (Pubitemid 46803047)
21. Song L, Webb NE, Song Y, Tuan RS. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells. 2006;24:1707-1718. (Pubitemid 44474184)
22. Abdallah BM, Haack-Sorensen M, Burns JS, et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun. 2005;326:527-538. (Pubitemid 39642757)
23. Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20:592-596. (Pubitemid 34595153)
24. Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, Kassem M. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res. 2007;22:1720-1731. (Pubitemid 351235138)
25. Frederiksen CM, Knudsen S, Laurberg S, Orntoft TF. Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol. 2003;129:263-271. (Pubitemid 36791681)
26. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003; 31.
27. Al-Shahrour F, Minguez P, Vaquerizas JM, Conde L,Dopazo J. BABELOMICS: a suite of Web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res. 2005;33. (Pubitemid 44529962)
28. Gollner H, Dani C, Phillips B, Philipsen S, Suske G. Impaired ossification in mice lacking the transcription factor Sp3. Mech Dev. 2001;106:77-83. (Pubitemid 32701075)
29. Chan YM, Bonnemann CG, Lidov HG, Kunkel LM. Molecular organization of sarcoglycan complex in mouse myotubes in culture. J Cell Biol. 1998;143:2033-2044.
30. Liu LA, Engvall E. Sarcoglycan isoforms in skeletal muscle. J Biol Chem. 1999;274:38171-38176.
31. Heyninck K, Beyaert R. Crosstalk between NF-κB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol Cell Biol Res Commun. 2001; 4. (Pubitemid 32879079)
32. Hildebrand A, Romaris M, Rasmussen LM, et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J. 1994;302:527-534.
33. Corsi A, Xu T, Chen XD, et al. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 2002;17:1180-1189.
34. Reinboth B, Hanssen E, Cleary EG, Gibson MA. Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J Biol Chem. 2002;277:3950-3957.
35. Trask BC, Trask TM, Broekelmann T, Mecham RP. The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol Biol Cell. 2000;11:1499-1507.
36. Raouf A, Ganss B, McMahon C, Vary C, Roughley PJ, Seth A. Lumican is a major proteoglycan component of the bone matrix. Matrix Biol. 2002; 21. (Pubitemid 34786472)
37. Raouf A, Seth A. Discovery of osteoblast-associated genes using cDNA microarrays. Bone. 2002;30:463-471. (Pubitemid 34204120)
38. Kim MS, Kim SS, Jung ST, et al. Expression and purification of enzymatically active forms of the human lysyl oxidase-like protein 4. J Biol Chem. 2003;278:52071-52074.
39. Maki JM, Sormunen R, Lippo S, Kaarteenaho-Wiik R, Soininen R, Myllyharju J. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol. 2005;167:927-936.
40. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:1417-1426.
41. Wewer UM, Ibaraki K, Schjorring P, Durkin ME, Young MF, Albrechtsen R. A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol. 1994;127:1767-1775. (Pubitemid 24380912)
42. Potter LR, Bbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27:47-72.
43. Matsukawa N, Grzesik WJ, Takahashi N, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA. 1999;96:7403-7408. (Pubitemid 29299674)
44. Jaubert J, Jaubert F, Martin N, et al. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci USA. 1999;96:10278-10283. (Pubitemid 29422549)
45. Hagiwara H, Inoue A, Yamaguchi A, et al. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am J Physiol. 1996;270:C1311-C1318. (Pubitemid 126756690)
46. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-319.
47. Simeone A, Acampora D, Pannese M, et al. Cloning and characterization of two members of the vertebrate Dlx gene family. Proc Natl Acad Sci USA. 1994;91:2250-2254. (Pubitemid 24092081)
48. Lee MH, Kim YJ, Yoon WJ, et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem. 2005;280:35579-35587.
49. Puppin C, Fabbro D, Dima M, et al. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J Endocrinol. 2008;197:401-408. (Pubitemid 351696253)
50. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for α(V)β(3) and α(V)β(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358-5364.
51. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294:271-278. (Pubitemid 23251940)
52. Rios H, Koushik SV, Wang H, et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005;25:11131-11144. (Pubitemid 41747153)
53. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. Periostin: a member of a novel family of vitamin K-dependent proteins is expressed by mesenchymal stromal cells. J Biol Chem. 2008;283:17991-18001.
54. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795-823.
55. Mann GN, Jacobs TW, Buchinsky FJ, et al. Interferon-γ causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology. 1994;135:1077-1083. (Pubitemid 24271201)
56. 3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism. Endocrinology. 1990;127:588-594.
57. Takayanagi H, Sato K, Takaoka A, Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev. 2005;208:181-193. (Pubitemid 41746393)
58. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131:324-336.
59. Liu F, Malaval L, Aubin JE. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J Cell Sci. 2003;116:1787-1796.